What The Pitt gets right about AI and clinical notes
In Season 2 of The Pitt, Dr. Santos accepts an AI-drafted clinical note and moves on. It’s one of...
Why diagnosis codes alone fall short for long COVID surveillance
When our client, a global pharmaceutical company, set out to better understand long COVID pathways,...
GenAI vs. Agentic AI: The difference for real-world evidence
AI is playing a growing role in real-world evidence, but not all AI serves the same purpose. Two...
Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
Disrupting Healthcare Audiences: A new standard for precision and accuracy
"Healthcare audience targeting has changed fast, and expectations have climbed even faster." As...
.png)
Building guardrails for AI-driven real-world data programs
AI is rapidly reshaping how real-world data (RWD) is generated and analyzed across healthcare...
5 questions RWE & HEOR teams should ask data vendors in an RFP
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal...
Primary biliary cholangitis: Disease burden, treatments and RWD gaps
Understanding PBC and today’s treatment landscape Primary biliary cholangitis (PBC) is a chronic...
Insights in healthcare marketing start with truth, not inference
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...